Neil Ari Wijetunga

9PUBLICATIONS
70CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersGene expression (incl. microarray and other genome-wide approaches)Instruments and techniquesInformetrics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Sep 23, 2026
CXCL1-CXCR2 signaling mediates cancer cell growth and response to radiation therapy in leptomeningeal metastasis.

|May 14, 2026
Multimodal Impact of Number of Metastases and Genetic Alterations on Survival in Metastatic Non-Small Cell Lung Cancer.

|Aug 08, 2024
Poor Prognosis among Radiation-Associated Bladder Cancer Is Defined by Clinicogenomic Features.

N Ari Wijetunga, Kathryn H Gessner, Krishna Kanchi

|Nov 30, 2022
Dynamic Mutational Landscape of Cerebrospinal Fluid Circulating Tumor DNA and Predictors of Survival after Proton Craniospinal Irradiation for Leptomeningeal Metastases.

N Ari Wijetunga, Alexander G Goglia, Nils Weinhold

|Sep 30, 2022
Genomic insights into host and parasite interactions during intracellular infection by Toxoplasma gondii.

Netha Ulahannan, Ronald Cutler, Reanna Doña-Termine

|Jul 08, 2022
Randomized Phase II Trial of Proton Craniospinal Irradiation Versus Photon Involved-Field Radiotherapy for Patients With Solid Tumor Leptomeningeal Metastasis.

Jonathan T Yang, N Ari Wijetunga, Elena Pentsova

Pageof 2

Frequent Collaborators

4 joint publications

Adrienne Boire

2 joint publications

Rachna Malani

2 joint publications

Jonathan T Yang

2 joint publications

Ahmed M Osman